Fig. 4 | Scientific Reports

Fig. 4

From: CKAAKN peptide-conjugated long-circulating nanoliposomes for the targeted delivery of oridonin to pancreatic cancers

Fig. 4

Preparation, characterization, and stealth properties of ORI-loaded liposomal formulations. (A) Visual appearance under daylight and Tyndall light scattering of ORI@Lipo and ORI@CPD-Lipo. (B) Particle size distribution of ORI@CPD-Lipo. (C) Representative TEM images of (a) ORI@Lipo and (b) ORI@CPD-Lipo. (D) Coomassie Brilliant Blue-stained SDS-PAGE gel. The full, uncropped image of this gel is provided in the Supplementary Material. (E) Grayscale analysis of major opsonin bands (37–50 kDa) using ImageJ. (F) In vitro drug release profiles of free ORI, ORI@Lipo, and ORI@CPD-Lipo in PBS (pH 7.4).

Back to article page